Histone methyltransferases: Novel targets for tumor and developmental defects

American Journal of Translational Research

Volumn 7, Issue 11, 2015, Pages 2159-2175

  Yi, Xin ^a,b   Jiang, Xue Jun ^a,b   Li, Xiao Yan ^a,b   Jiang, Ding Sheng ^c  

^a RENMIN HOSPITAL OF WUHAN UNIVERSITY   (China)

^b WUHAN UNIVERSITY   (China)

^c HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

Epigenetic modification; Histone lysine methylation; Histone methyltransferases

Indexed keywords

CYCLIN E; ENHANCER OF ZESTE; H3K27 PROTEIN; H3K36 PROTEIN; H3K79 PROTEIN; H3K9 PROTEIN; H4K20 PROTEIN; HISTONE LYSINE METHYLTRANSFERASE; HISTONE METHYLTRANSFERASE; INTERLEUKIN 6; NUCLEAR RECEPTOR SET DOMAIN 1; NUCLEAR RECEPTOR SET DOMAIN 2; ORIGIN RECOGNITION COMPLEX; PEPTIDES AND PROTEINS; PROTEIN ARGININE METHYLTRANSFERASE; SET DOMAIN 2; SUPPRESSOR OF VARIEGATION; TRITHORAX; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

BREAST CANCER; CARCINOGENESIS; CELL CYCLE; DEVELOPMENTAL DISORDER; DISEASE COURSE; ENZYME ACTIVITY; GENE CONTROL; GENE EXPRESSION; GENE MUTATION; GENETIC TRANSCRIPTION; GENOME IMPRINTING; GLIOMA; HISTONE METHYLATION; HUMAN; INHERITANCE; LEUKEMIA; NEOPLASM; NEUROBLASTOMA; NON SMALL CELL LUNG CANCER; NONHUMAN; OPEN READING FRAME; REVIEW;

EID: 84950107821     PISSN: None     EISSN: 19438141     Source Type: Journal    
DOI: None     Document Type: Review

References (132)

1. Tessarz P and Kouzarides T. Histone core modifications regulating nucleosome structure and dynamics. Nat Rev Mol Cell Biol 2014; 15: 703-708.
2. Lavelle C and Foray N. Chromatin structure and radiation-induced DNA damage: from structural biology to radiobiology. Int J Biochem Cell Biol 2014; 49: 84-97.
3. Fullgrabe J, Hajji N and Joseph B. Cracking the death code: apoptosis-related histone modifications. Cell Death Differ 2010; 17: 1238-1243.
4. Nikitina T, Wang D, Gomberg M, Grigoryev SA and Zhurkin VB. Combined micrococcal nuclease and exonuclease III digestion reveals precise positions of the nucleosome core/linker junctions: implications for high-resolution nucleosome mapping. J Mol Biol 2013; 425: 1946-1960.
5. Caterino TL, Fang H and Hayes JJ. Nucleosome linker DNA contacts and induces specific folding of the intrinsically disordered H1 carboxylterminal domain. Mol Cell Biol 2011; 31: 2341-2348.
6. Chen HP, Zhao YT and Zhao TC. Histone deacetylases and mechanisms of regulation of gene expression. Crit Rev Oncog 2015; 20: 35-47.
7. Geranton SM and Tochiki KK. Regulation of gene expression and pain states by epigenetic mechanisms. Prog Mol Biol Transl Sci 2015; 131: 147-183.
8. Lewis BA and Hanover JA. O-GlcNAc and the epigenetic regulation of gene expression. J Biol Chem 2014; 289: 34440-34448.
9. Song ZT, Sun L, Lu SJ, Tian Y, Ding Y and Liu JX. Transcription factor interaction with COMPASSlike complex regulates histone H3K4 trimethylation for specific gene expression in plants. Proc Natl Acad Sci U S A 2015; 112: 2900-2905.
10. Leung D, Jung I, Rajagopal N, Schmitt A, Selvaraj S, Lee AY, Yen CA, Lin S, Lin Y, Qiu Y, Xie W, Yue F, Hariharan M, Ray P, Kuan S, Edsall L, Yang H, Chi NC, Zhang MQ, Ecker JR and Ren B. Integrative analysis of haplotype-resolved epigenomes across human tissues. Nature 2015; 518: 350-354.
11. Gatti M, Pinato S, Maiolica A, Rocchio F, Prato MG, Aebersold R and Penengo L. RNF168 promotes noncanonical K27 ubiquitination to signal DNA damage. Cell Rep 2015; 10: 226-238.
12. Sakamoto A, Hino S, Nagaoka K, Anan K, Takase R, Matsumori H, Ojima H, Kanai Y, Arita K and Nakao M. Lysine Demethylase LSD1 Coordinates Glycolytic and Mitochondrial Metabolism in Hepatocellular Carcinoma Cells. Cancer Res 2015; 75: 1445-1456.
13. Van Rechem C and Whetstine JR. Examining the impact of gene variants on histone lysine methylation. Biochim Biophys Acta 2014; 1839: 1463-1476.
14. Di Lorenzo A and Bedford MT. Histone arginine methylation. FEBS Lett 2011; 585: 2024-2031.
15. Thakur JK, Malik MR, Bhatt V, Reddy MK, Sopory SK, Tyagi AK and Khurana JP. A POLYCOMB group gene of rice (Oryza sativa L. subspecies indica), OsiEZ1, codes for a nuclearlocalized protein expressed preferentially in young seedlings and during reproductive development. Gene 2003; 314: 1-13.
16. Min J, Zhang X, Cheng X, Grewal SI and Xu RM. Structure of the SET domain histone lysine methyltransferase Clr4. Nat Struct Biol 2002; 9: 828-832.
17. Qian Y, Xi Y, Cheng B, Zhu S and Kan X. Identification and characterization of the SET domain gene family in maize. Mol Biol Rep 2014; 41: 1341-1354.
18. Binda O. On your histone mark, SET, methylate! Epigenetics 2013; 8: 457-463.
19. Qian C and Zhou MM. SET domain protein lysine methyltransferases: Structure, specificity and catalysis. Cell Mol Life Sci 2006; 63: 2755-2763.
20. Del Rizzo PA and Trievel RC. Substrate and product specificities of SET domain methyltransferases. Epigenetics 2011; 6: 1059-1067.
21. Dillon SC, Zhang X, Trievel RC and Cheng X. The SET-domain protein superfamily: protein lysine methyltransferases. Genome Biol 2005; 6: 227.
22. Yeates TO. Structures of SET domain proteins: protein lysine methyltransferases make their mark. Cell 2002; 111: 5-7.
23. Zhang X and Bruice TC. Enzymatic mechanism and product specificity of SET-domain protein lysine methyltransferases. Proc Natl Acad Sci U S A 2008; 105: 5728-5732.
24. Valencia-Morales Mdel P, Camas-Reyes JA, Cabrera-Ponce JL and Alvarez-Venegas R. The Arabidopsis thaliana SET-domain-containing protein ASHH1/SDG26 interacts with itself and with distinct histone lysine methyltransferases. J Plant Res 2012; 125: 679-692.
25. Hu P, Wang S and Zhang Y. How do SET-domain protein lysine methyltransferases achieve the methylation state specificity? Revisited by Ab initio QM/MM molecular dynamics simulations. J Am Chem Soc 2008; 130: 3806-3813.
26. Wilson JR, Jing C, Walker PA, Martin SR, Howell SA, Blackburn GM, Gamblin SJ and Xiao B. Crystal structure and functional analysis of the histone methyltransferase SET7/9. Cell 2002; 111: 105-115.
27. Zhang X, Tamaru H, Khan SI, Horton JR, Keefe LJ, Selker EU and Cheng X. Structure of the Neurospora SET domain protein DIM-5, a histone H3 lysine methyltransferase. Cell 2002; 111: 117-127.
28. Zhang X, Yang Z, Khan SI, Horton JR, Tamaru H, Selker EU and Cheng X. Structural basis for the product specificity of histone lysine methyltransferases. Mol Cell 2003; 12: 177-185.
29. An S, Yeo KJ, Jeon YH and Song JJ. Crystal structure of the human histone methyltransferase ASH1L catalytic domain and its implications for the regulatory mechanism. J Biol Chem 2011; 286: 8369-8374.
30. Huang S, Shao G and Liu L. The PR domain of the Rb-binding zinc finger protein RIZ1 is a protein binding interface and is related to the SET domain functioning in chromatin-mediated gene expression. J Biol Chem 1998; 273: 15933-15939.
31. Yakubov E, Dinerman P, Kuperstein F, Saban S and Yavin E. Improved representation of gene markers on microarray by PCR-Select subtracted cDNA targets. Brain Res Mol Brain Res 2005; 137: 110-118.
32. Xu Q and Dunbrack RL Jr. Assignment of protein sequences to existing domain and family classification systems: Pfam and the PDB. Bioinformatics 2012; 28: 2763-2772.
33. Spellmon N, Holcomb J, Trescott L, Sirinupong N and Yang Z. Structure and function of SET and MYND domain-containing proteins. Int J Mol Sci 2015; 16: 1406-1428.
34. Berr A, Shafiq S, Pinon V, Dong A and Shen WH. The trxG family histone methyltransferase SET DOMAIN GROUP 26 promotes flowering via a distinctive genetic pathway. Plant J 2015; 81: 316-328.
35. Alvarez-Venegas R. Bacterial SET domain proteins and their role in eukaryotic chromatin modification. Front Genet 2014; 5: 65.
36. Congdon LM, Sims JK, Tuzon CT and Rice JC. The PR-Set7 binding domain of Riz1 is required for the H4K20me1-H3K9me1 trans-tail ‘histone code’ and Riz1 tumor suppressor function. Nucleic Acids Res 2014; 42: 3580-3589.
37. Wu H, Siarheyeva A, Zeng H, Lam R, Dong A, Wu XH, Li Y, Schapira M, Vedadi M and Min J. Crystal structures of the human histone H4K20 methyltransferases SUV420H1 and SUV420H2. FEBS Lett 2013; 587: 3859-3868.
38. Schultz DC, Ayyanathan K, Negorev D, Maul GG and Rauscher FJ 3rd. SETDB1: a novel KAP-1-associated histone H3, lysine 9-specific methyltransferase that contributes to HP1-mediated silencing of euchromatic genes by KRAB zinc-finger proteins. Genes Dev 2002; 16: 919-932.
39. Du TT, Xu PF, Dong ZW, Fan HB, Jin Y, Dong M, Chen Y, Pan WJ, Ren RB, Liu TX, Deng M and Huang QH. Setdb2 controls convergence and extension movements during zebrafish gastrulation by transcriptional regulation of dvr1. Dev Biol 2014; 392: 233-244.
40. Rothbart SB, Dickson BM and Strahl BD. From histones to ribosomes: a chromatin regulator tangoes with translation. Cancer Discov 2015; 5: 228-230.
41. Wozniak GG and Strahl BD. Hitting the ‘mark’: interpreting lysine methylation in the context of active transcription. Biochim Biophys Acta 2014; 1839: 1353-1361.
42. Lan F and Shi Y. Epigenetic regulation: methylation of histone and non-histone proteins. Sci China C Life Sci 2009; 52: 311-322.
43. Herz HM, Garruss A and Shilatifard A. SET for life: biochemical activities and biological functions of SET domain-containing proteins. Trends Biochem Sci 2013; 38: 621-639.
44. Niwa H, Handa N, Tomabechi Y, Honda K, Toyama M, Ohsawa N, Shirouzu M, Kagechika H, Hirano T, Umehara T and Yokoyama S. Structures of histone methyltransferase SET7/9 in complexes with adenosylmethionine derivatives. Acta Crystallogr D Biol Crystallogr 2013; 69: 595-602.
45. Liu N, Zhang Z, Wu H, Jiang Y, Meng L, Xiong J, Zhao Z, Zhou X, Li J, Li H, Zheng Y, Chen S, Cai T, Gao S and Zhu B. Recognition of H3K9 methylation by GLP is required for efficient establishment of H3K9 methylation, rapid target gene repression, and mouse viability. Genes Dev 2015; 29: 379-393.
46. Inoue S, Honma K, Mochizuki K and Goda T. Induction of histone H3K4 methylation at the promoter, enhancer, and transcribed regions of the Si and Sglt1 genes in rat jejunum in response to a high-starch/low-fat diet. Nutrition 2015; 31: 366-372.
47. Lillycrop KA and Burdge GC. Environmental challenge, epigenetic plasticity and the induction of altered phenotypes in mammals. Epigenomics 2014; 6: 623-636.
48. Sadakierska-Chudy A and Filip M. A comprehensive view of the epigenetic landscape. Part II: Histone post-translational modification, nucleosome level, and chromatin regulation by ncRNAs. Neurotox Res 2015; 27: 172-197.
49. Kim EJ, Ma X and Cerutti H. Gene silencing in microalgae: mechanisms and biological roles. Bioresour Technol 2015; 184: 23-32.
50. Hu J, Chen S, Kong X, Zhu K, Cheng S, Zheng M, Jiang H and Luo C. Interaction between DNA/histone methyltransferases and their inhibitors. Curr Med Chem 2015; 22: 360-372.
51. Wakeman TP, Wang Q, Feng J and Wang XF. Bat3 facilitates H3K79 dimethylation by DOT1L and promotes DNA damage-induced 53BP1 foci at G1/G2 cell-cycle phases. EMBO J 2012; 31: 2169-2181.
52. Garcia-Cao M, O’Sullivan R, Peters AH, Jenuwein T and Blasco MA. Epigenetic regulation of telomere length in mammalian cells by the Suv39h1 and Suv39h2 histone methyltransferases. Nat Genet 2004; 36: 94-99.
53. Muramatsu D, Singh PB, Kimura H, Tachibana M and Shinkai Y. Pericentric heterochromatin generated by HP1 protein interaction-defective histone methyltransferase Suv39h1. J Biol Chem 2013; 288: 25285-25296.
54. Kalish JM, Jiang C and Bartolomei MS. Epigenetics and imprinting in human disease. Int J Dev Biol 2014; 58: 291-298.
55. Weaver JR and Bartolomei MS. Chromatin regulators of genomic imprinting. Biochim Biophys Acta 2014; 1839: 169-177.
56. Chaumeil J, Waters PD, Koina E, Gilbert C, Robinson TJ and Graves JA. Evolution from XIST-independent to XIST-controlled X-chromosome inactivation: epigenetic modifications in distantly related mammals. PLoS One 2011; 6: e19040.
57. He L, Yu JX, Liu L, Buyse IM, Wang MS, Yang QC, Nakagawara A, Brodeur GM, Shi YE and Huang S. RIZ1, but not the alternative RIZ2 product of the same gene, is underexpressed in breast cancer, and forced RIZ1 expression causes G2-M cell cycle arrest and/or apoptosis. Cancer Res 1998; 58: 4238-4244.
58. Canote R, Du Y, Carling T, Tian F, Peng Z and Huang S. The tumor suppressor gene RIZ in cancer gene therapy (review). Oncol Rep 2002; 9: 57-60.
59. Deng Q and Huang S. PRDM5 is silenced in human cancers and has growth suppressive activities. Oncogene 2004; 23: 4903-4910.
60. Czvitkovich S, Sauer S, Peters AH, Deiner E, Wolf A, Laible G, Opravil S, Beug H and Jenuwein T. Over-expression of the SUV39H1 histone methyltransferase induces altered proliferation and differentiation in transgenic mice. Mech Dev 2001; 107: 141-153.
61. Yokoyama A, Wang Z, Wysocka J, Sanyal M, Aufiero DJ, Kitabayashi I, Herr W and Cleary ML. Leukemia proto-oncoprotein MLL forms a SET1-like histone methyltransferase complex with menin to regulate Hox gene expression. Mol Cell Biol 2004; 24: 5639-5649.
62. Paneni F, Costantino S, Battista R, Castello L, Capretti G, Chiandotto S, Scavone G, Villano A, Pitocco D, Lanza G, Volpe M, Luscher TF and Cosentino F. Adverse epigenetic signatures by histone methyltransferase Set7 contribute to vascular dysfunction in patients with type 2 diabetes mellitus. Circ Cardiovasc Genet 2015; 8: 150-158.
63. Goldsworthy M, Absalom NL, Schroter D, Matthews HC, Bogani D, Moir L, Long A, Church C, Hugill A, Anstee QM, Goldin R, Thursz M, Hollfelder F and Cox RD. Mutations in Mll2, an H3K4 methyltransferase, result in insulin resistance and impaired glucose tolerance in mice. PLoS One 2013; 8: e61870.
64. Jha DK and Strahl BD. An RNA polymerase IIcoupled function for histone H3K36 methylation in checkpoint activation and DSB repair. Nat Commun 2014; 5: 3965.
65. Kimura H. Histone modifications for human epigenome analysis. J Hum Genet 2013; 58: 439-445.
66. Hossain MA, Chung C, Pradhan SK and Johnson TL. The yeast cap binding complex modulates transcription factor recruitment and establishes proper histone H3K36 trimethylation during active transcription. Mol Cell Biol 2013; 33: 785-799.
67. Venkatesh S, Smolle M, Li H, Gogol MM, Saint M, Kumar S, Natarajan K and Workman JL. Set2 methylation of histone H3 lysine 36 suppresses histone exchange on transcribed genes. Nature 2012; 489: 452-455.
68. Maltby VE, Martin BJ, Schulze JM, Johnson I, Hentrich T, Sharma A, Kobor MS and Howe L. Histone H3 lysine 36 methylation targets the Isw1b remodeling complex to chromatin. Mol Cell Biol 2012; 32: 3479-3485.
69. Del Rizzo PA and Trievel RC. Molecular basis for substrate recognition by lysine methyltransferases and demethylases. Biochim Biophys Acta 2014; 1839: 1404-1415.
70. Wagner EJ and Carpenter PB. Understanding the language of Lys36 methylation at histone H3. Nat Rev Mol Cell Biol 2012; 13: 115-126.
71. Xu G, Liu G, Xiong S, Liu H, Chen X and Zheng B. The histone methyltransferase Smyd2 is a negative regulator of macrophage activation by suppressing interleukin 6 (IL-6) and tumor necrosis factor alpha (TNF-alpha) production. J Biol Chem 2015; 290: 5414-5423.
72. van Nuland R, van Schaik FM, Simonis M, van Heesch S, Cuppen E, Boelens R, Timmers HM and van Ingen H. Nucleosomal DNA binding drives the recognition of H3K36-methylated nucleosomes by the PSIP1-PWWP domain. Epigenetics Chromatin 2013; 6: 12.
73. Endo H, Nakabayashi Y, Kawashima S, Enomoto T, Seki M and Horikoshi M. Nucleosome surface containing nucleosomal DNA entry/ exit site regulates H3-K36me3 via association with RNA polymerase II and Set2. Genes Cells 2012; 17: 65-81.
74. Sakhon OS, Victor KA, Choy A, Tsuchiya T, Eulgem T and Pedra JH. NSD1 mitigates caspase-1 activation by listeriolysin O in macrophages. PLoS One 2013; 8: e75911.
75. Wang GG, Cai L, Pasillas MP and Kamps MP. NUP98-NSD1 links H3K36 methylation to Hox-A gene activation and leukaemogenesis. Nat Cell Biol 2007; 9: 804-812.
76. Popovic R, Martinez-Garcia E, Giannopoulou EG, Zhang Q, Zhang Q, Ezponda T, Shah MY, Zheng Y, Will CM, Small EC, Hua Y, Bulic M, Jiang Y, Carrara M, Calogero RA, Kath WL, Kelleher NL, Wang JP, Elemento O and Licht JD. Histone methyltransferase MMSET/NSD2 alters EZH2 binding and reprograms the myeloma epigenome through global and focal changes in H3K36 and H3K27 methylation. PLoS Genet 2014; 10: e1004566.
77. Zheng Y, Sweet SM, Popovic R, Martinez-Garcia E, Tipton JD, Thomas PM, Licht JD and Kelleher NL. Total kinetic analysis reveals how combinatorial methylation patterns are established on lysines 27 and 36 of histone H3. Proc Natl Acad Sci U S A 2012; 109: 13549-13554.
78. Morishita M, Mevius D and di Luccio E. In vitro histone lysine methylation by NSD1, NSD2/ MMSET/WHSC1 and NSD3/WHSC1L. BMC Struct Biol 2014; 14: 25.
79. Kuo AJ, Cheung P, Chen K, Zee BM, Kioi M, Lauring J, Xi Y, Park BH, Shi X, Garcia BA, Li W and Gozani O. NSD2 links dimethylation of histone H3 at lysine 36 to oncogenic programming. Mol Cell 2011; 44: 609-620.
80. Morishita M and di Luccio E. Cancers and the NSD family of histone lysine methyltransferas es. Biochim Biophys Acta 2011; 1816: 158-163.
81. Bannister AJ, Schneider R, Myers FA, Thorne AW, Crane-Robinson C and Kouzarides T. Spatial distribution of di-and tri-methyl lysine 36 of histone H3 at active genes. J Biol Chem 2005; 280: 17732-17736.
82. Edmunds JW, Mahadevan LC and Clayton AL. Dynamic histone H3 methylation during gene induction: HYPB/Setd2 mediates all H3K36 trimethylation. EMBO J 2008; 27: 406-420.
83. Pfister SX, Ahrabi S, Zalmas LP, Sarkar S, Aymard F, Bachrati CZ, Helleday T, Legube G, La Thangue NB, Porter AC and Humphrey TC. SETD2-dependent histone H3K36 trimethylation is required for homologous recombination repair and genome stability. Cell Rep 2014; 7: 2006-2018.
84. Gao YG, Yang H, Zhao J, Jiang YJ and Hu HY. Autoinhibitory structure of the WW domain of HYPB/SETD2 regulates its interaction with the proline-rich region of huntingtin. Structure 2014; 22: 378-386.
85. Sun XJ, Wei J, Wu XY, Hu M, Wang L, Wang HH, Zhang QH, Chen SJ, Huang QH and Chen Z. Identification and characterization of a novel human histone H3 lysine 36-specific methyltransferase. J Biol Chem 2005; 280: 35261-35271.
86. Yuan W, Xie J, Long C, Erdjument-Bromage H, Ding X, Zheng Y, Tempst P, Chen S, Zhu B and Reinberg D. Heterogeneous nuclear ribonucleoprotein L Is a subunit of human KMT3a/ Set2 complex required for H3 Lys-36 trimethylation activity in vivo. J Biol Chem 2009; 284: 15701-15707.
87. Park D, Shivram H and Iyer VR. Chd1 co-localizes with early transcription elongation factors independently of H3K36 methylation and releases stalled RNA polymerase II at introns. Epigenetics Chromatin 2014; 7: 32.
88. Eram MS, Bustos SP, Lima-Fernandes E, Siarheyeva A, Senisterra G, Hajian T, Chau I, Duan S, Wu H, Dombrovski L, Schapira M, Arrowsmith CH and Vedadi M. Trimethylation of histone H3 lysine 36 by human methyltransferase PRDM9 protein. J Biol Chem 2014; 289: 12177-12188.
89. Kim DW, Kim KB, Kim JY and Seo SB. Characterization of a novel histone H3K36 methyltransferase setd3 in zebrafish. Biosci Biotechnol Biochem 2011; 75: 289-294.
90. Ginsburg DS, Anlembom TE, Wang J, Patel SR, Li B and Hinnebusch AG. NuA4 links methylation of histone H3 lysines 4 and 36 to acetylation of histones H4 and H3. J Biol Chem 2014; 289: 32656-32670.
91. Lee YF, Nimura K, Lo WN, Saga K and Kaneda Y. Histone H3 lysine 36 methyltransferase Whsc1 promotes the association of Runx2 and p300 in the activation of bone-related genes. PLoS One 2014; 9: e106661.
92. Diao YF, Oqani RK, Li XX, Lin T, Kang JW and Jin DI. Changes in histone H3 lysine 36 methylation in porcine oocytes and preimplantation embryos. PLoS One 2014; 9: e100205.
93. Wen H, Li Y, Xi Y, Jiang S, Stratton S, Peng D, Tanaka K, Ren Y, Xia Z, Wu J, Li B, Barton MC, Li W, Li H and Shi X. ZMYND11 links histone H3.3K36me3 to transcription elongation and tumour suppression. Nature 2014; 508: 263-268.
94. Li B, Gogol M, Carey M, Lee D, Seidel C and Workman JL. Combined action of PHD and chromo domains directs the Rpd3S HDAC to transcribed chromatin. Science 2007; 316: 1050-1054.
95. Joshi AA and Struhl K. Eaf3 chromodomain interaction with methylated H3-K36 links histone deacetylation to Pol II elongation. Mol Cell 2005; 20: 971-978.
96. Carrozza MJ, Li B, Florens L, Suganuma T, Swanson SK, Lee KK, Shia WJ, Anderson S, Yates J, Washburn MP and Workman JL. Histone H3 methylation by Set2 directs deacetylation of coding regions by Rpd3S to suppress spurious intragenic transcription. Cell 2005; 123: 581-592.
97. Lucio-Eterovic AK, Singh MM, Gardner JE, Veerappan CS, Rice JC and Carpenter PB. Role for the nuclear receptor-binding SET domain protein 1 (NSD1) methyltransferase in coordinating lysine 36 methylation at histone 3 with RNA polymerase II function. Proc Natl Acad Sci U S A 2010; 107: 16952-16957.
98. Fang R, Barbera AJ, Xu Y, Rutenberg M, Leonor T, Bi Q, Lan F, Mei P, Yuan GC, Lian C, Peng J, Cheng D, Sui G, Kaiser UB, Shi Y and Shi YG. Human LSD2/KDM1b/AOF1 regulates gene transcription by modulating intragenic H3K4me2 methylation. Mol Cell 2010; 39: 222-233.
99. Pryde F, Jain D, Kerr A, Curley R, Mariotti FR and Vogelauer M. H3 k36 methylation helps determine the timing of cdc45 association with replication origins. PLoS One 2009; 4: e5882.
100. Kim HS, Rhee DK and Jang YK. Methylations of histone H3 lysine 9 and lysine 36 are functionally linked to DNA replication checkpoint control in fission yeast. Biochem Biophys Res Commun 2008; 368: 419-425.
101. Li F, Mao G, Tong D, Huang J, Gu L, Yang W and Li GM. The histone mark H3K36me3 regulates human DNA mismatch repair through its interaction with MutSalpha. Cell 2013; 153: 590-600.
102. Akiki S, Dyer SA, Grimwade D, Ivey A, Abou-Zeid N, Borrow J, Jeffries S, Caddick J, Newell H, Begum S, Tawana K, Mason J, Velangi M and Griffiths M. NUP98-NSD1 fusion in association with FLT3-ITD mutation identifies a prognostically relevant subgroup of pediatric acute myeloid leukemia patients suitable for monitoring by real time quantitative PCR. Genes Chromosomes Cancer 2013; 52: 1053-1064.
103. Tatton-Brown K and Rahman N. The NSD1 and EZH2 overgrowth genes, similarities and differences. Am J Med Genet C Semin Med Genet 2013; 163C: 86-91.
104. Cross NC. Histone modification defects in developmental disorders and cancer. Oncotarget 2012; 3: 3-4.
105. Keats JJ, Maxwell CA, Taylor BJ, Hendzel MJ, Chesi M, Bergsagel PL, Larratt LM, Mant MJ, Reiman T, Belch AR and Pilarski LM. Overexpression of transcripts originating from the MMSET locus characterizes all t(4;14) (p16;q32)-positive multiple myeloma patients. Blood 2005; 105: 4060-4069.
106. Douglas J, Coleman K, Tatton-Brown K, Hughes HE, Temple IK, Cole TR, Rahman N; Childhood Overgrowth Collaboration. Evaluation of NSD2 and NSD3 in overgrowth syndromes. Eur J Hum Genet 2005; 13: 150-153.
107. Svedlund J, Koskinen Edblom S, Marquez VE, Akerstrom G, Bjorklund P and Westin G. Hypermethylated in cancer 1 (HIC1), a tumor suppressor gene epigenetically deregulated in hyperparathyroid tumors by histone H3 lysine modification. J Clin Endocrinol Metab 2012; 97: E1307-1315.
108. Deshpande AJ, Deshpande A, Sinha AU, Chen L, Chang J, Cihan A, Fazio M, Chen CW, Zhu N, Koche R, Dzhekieva L, Ibanez G, Dias S, Banka D, Krivtsov A, Luo M, Roeder RG, Bradner JE, Bernt KM and Armstrong SA. AF10 regulates progressive H3K79 methylation and HOX gene expression in diverse AML subtypes. Cancer Cell 2014; 26: 896-908.
109. Drake KM, Watson VG, Kisielewski A, Glynn R and Napper AD. A sensitive luminescent assay for the histone methyltransferase NSD1 and other SAM-dependent enzymes. Assay Drug Dev Technol 2014; 12: 258-271.
110. Shiba N, Ichikawa H, Taki T, Park MJ, Jo A, Mitani S, Kobayashi T, Shimada A, Sotomatsu M, Arakawa H, Adachi S, Tawa A, Horibe K, Tsuchida M, Hanada R, Tsukimoto I and Hayashi Y. NUP98-NSD1 gene fusion and its related gene expression signature are strongly associated with a poor prognosis in pediatric acute myeloid leukemia. Genes Chromosomes Cancer 2013; 52: 683-693.
111. Migdalska AM, van der Weyden L, Ismail O, Sanger Mouse Genetics P, Rust AG, Rashid M, White JK, Sanchez-Andrade G, Lupski JR, Logan DW, Arends MJ and Adams DJ. Generation of the Sotos syndrome deletion in mice. Mamm Genome 2012; 23: 749-757.
112. Jaffe JD, Wang Y, Chan HM, Zhang J, Huether R, Kryukov GV, Bhang HE, Taylor JE, Hu M, Englund NP, Yan F, Wang Z, Robert McDonald E 3rd, Wei L, Ma J, Easton J, Yu Z, deBeaumount R, Gibaja V, Venkatesan K, Schlegel R, Sellers WR, Keen N, Liu J, Caponigro G, Barretina J, Cooke VG, Mullighan C, Carr SA, Downing JR, Garraway LA and Stegmeier F. Global chromatin profiling reveals NSD2 mutations in pediatric acute lymphoblastic leukemia. Nat Genet 2013; 45: 1386-1391.
113. Oyer JA, Huang X, Zheng Y, Shim J, Ezponda T, Carpenter Z, Allegretta M, Okot-Kotber CI, Patel JP, Melnick A, Levine RL, Ferrando A, Mackerell AD Jr, Kelleher NL, Licht JD and Popovic R. Point mutation E1099K in MMSET/NSD2 enhances its methyltranferase activity and leads to altered global chromatin methylation in lymphoid malignancies. Leukemia 2014; 28: 198-201.
114. Angrand PO, Apiou F, Stewart AF, Dutrillaux B, Losson R and Chambon P. NSD3, a new SET domain-containing gene, maps to 8p12 and is amplified in human breast cancer cell lines. Genomics 2001; 74: 79-88.
115. Rosati R, La Starza R, Veronese A, Aventin A, Schwienbacher C, Vallespi T, Negrini M, Martelli MF and Mecucci C. NUP98 is fused to the NSD3 gene in acute myeloid leukemia associated with t(8;11)(p11.2;p15). Blood 2002; 99: 3857-3860.
116. Ostronoff F, Othus M, Gerbing RB, Loken MR, Raimondi SC, Hirsch BA, Lange BJ, Petersdorf S, Radich J, Appelbaum FR, Gamis AS, Alonzo TA and Meshinchi S. NUP98/NSD1 and FLT3/ ITD coexpression is more prevalent in younger AML patients and leads to induction failure: a COG and SWOG report. Blood 2014; 124: 2400-2407.
117. Berdasco M, Ropero S, Setien F, Fraga MF, Lapunzina P, Losson R, Alaminos M, Cheung NK, Rahman N and Esteller M. Epigenetic inactivation of the Sotos overgrowth syndrome gene histone methyltransferase NSD1 in human neuroblastoma and glioma. Proc Natl Acad Sci U S A 2009; 106: 21830-21835.
118. Zhao Q, Caballero OL, Levy S, Stevenson BJ, Iseli C, de Souza SJ, Galante PA, Busam D, Leversha MA, Chadalavada K, Rogers YH, Venter JC, Simpson AJ and Strausberg RL. Transcriptome-guided characterization of genomic rearrangements in a breast cancer cell line. Proc Natl Acad Sci U S A 2009; 106: 1886-1891.
119. Yang P, Guo L, Duan ZJ, Tepper CG, Xue L, Chen X, Kung HJ, Gao AC, Zou JX and Chen HW. Histone methyltransferase NSD2/MMSET mediates constitutive NF-kappaB signaling for cancer cell proliferation, survival, and tumor growth via a feed-forward loop. Mol Cell Biol 2012; 32: 3121-3131.
120. Sanidas I, Polytarchou C, Hatziapostolou M, Ezell SA, Kottakis F, Hu L, Guo A, Xie J, Comb MJ, Iliopoulos D and Tsichlis PN. Phosphoproteomics screen reveals akt isoformspecific signals linking RNA processing to lung cancer. Mol Cell 2014; 53: 577-590.
121. Gossage L, Murtaza M, Slatter AF, Lichtenstein CP, Warren A, Haynes B, Marass F, Roberts I, Shanahan SJ, Claas A, Dunham A, May AP, Rosenfeld N, Forshew T and Eisen T. Clinical and pathological impact of VHL, PBRM1, BAP1, SETD2, KDM6A, and JARID1c in clear cell renal cell carcinoma. Genes Chromosomes Cancer 2014; 53: 38-51.
122. Fontebasso AM, Schwartzentruber J, Khuong-Quang DA, Liu XY, Sturm D, Korshunov A, Jones DT, Witt H, Kool M, Albrecht S, Fleming A, Hadjadj D, Busche S, Lepage P, Montpetit A, Staffa A, Gerges N, Zakrzewska M, Zakrzewski K, Liberski PP, Hauser P, Garami M, Klekner A, Bognar L, Zadeh G, Faury D, Pfister SM, Jabado N and Majewski J. Mutations in SETD2 and genes affecting histone H3K36 methylation target hemispheric high-grade gliomas. Acta Neuropathol 2013; 125: 659-669.
123. Patani N, Jiang WG, Newbold RF and Mokbel K. Histone-modifier gene expression profiles are associated with pathological and clinical outcomes in human breast cancer. Anticancer Res 2011; 31: 4115-4125.
124. Wang Y, Thomas A, Lau C, Rajan A, Zhu Y, Killian JK, Petrini I, Pham T, Morrow B, Zhong X, Meltzer PS and Giaccone G. Mutations of epigenetic regulatory genes are common in thymic carcinomas. Sci Rep 2014; 4: 7336.
125. Sankin A, Hakimi AA, Mikkilineni N, Ostrovnaya I, Silk MT, Liang Y, Mano R, Chevinsky M, Motzer RJ, Solomon SB, Cheng EH, Durack JC, Coleman JA, Russo P and Hsieh JJ. The impact of genetic heterogeneity on biomarker development in kidney cancer assessed by multiregional sampling. Cancer Med 2014; 3: 1485-1492.
126. Kudithipudi S and Jeltsch A. Role of somatic cancer mutations in human protein lysine methyltransferases. Biochim Biophys Acta 2014; 1846: 366-379.
127. Hao C, Wang L, Peng S, Cao M, Li H, Hu J, Huang X, Liu W, Zhang H, Wu S, Pataer A, Heymach JV, Eterovic AK, Zhang Q, Shaw KR, Chen K, Futreal A, Wang M, Hofstetter W, Mehran R, Rice D, Roth JA, Sepesi B, Swisher SG, Vaporciyan A, Walsh GL, Johnson FM and Fang B. Gene mutations in primary tumors and corresponding patient-derived xenografts derived from non-small cell lung cancer. Cancer Lett 2015; 357: 179-185.
128. Mar BG, Bullinger LB, McLean KM, Grauman PV, Harris MH, Stevenson K, Neuberg DS, Sinha AU, Sallan SE, Silverman LB, Kung AL, Lo Nigro L, Ebert BL and Armstrong SA. Mutations in epigenetic regulators including SETD2 are gained during relapse in paediatric acute lymphoblastic leukaemia. Nat Commun 2014; 5: 3469.
129. Zhang K, Haversat JM and Mager J. CTR9/ PAF1c regulates molecular lineage identity, histone H3K36 trimethylation and genomic imprinting during preimplantation development. Dev Biol 2013; 383: 15-27.
130. Hu M, Sun XJ, Zhang YL, Kuang Y, Hu CQ, Wu WL, Shen SH, Du TT, Li H, He F, Xiao HS, Wang ZG, Liu TX, Lu H, Huang QH, Chen SJ and Chen Z. Histone H3 lysine 36 methyltransferase Hypb/Setd2 is required for embryonic vascular remodeling. Proc Natl Acad Sci U S A 2010; 107: 2956-2961.
131. Martinez HR, Belmont JW, Craigen WJ, Taylor MD and Jefferies JL. Left ventricular noncompaction in Sotos syndrome. Am J Med Genet A 2011; 155A: 1115-1118.
132. Nimura K, Ura K, Shiratori H, Ikawa M, Okabe M, Schwartz RJ and Kaneda Y. A histone H3 lysine 36 trimethyltransferase links Nkx2-5 to Wolf-Hirschhorn syndrome. Nature 2009; 460: 287-291.